Your browser doesn't support javascript.
loading
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.
Hines, Melissa R; Knight, Tristan E; McNerney, Kevin O; Leick, Mark B; Jain, Tania; Ahmed, Sairah; Frigault, Matthew J; Hill, Joshua A; Jain, Michael D; Johnson, William T; Lin, Yi; Mahadeo, Kris M; Maron, Gabriela M; Marsh, Rebecca A; Neelapu, Sattva S; Nikiforow, Sarah; Ombrello, Amanda K; Shah, Nirav N; Talleur, Aimee C; Turicek, David; Vatsayan, Anant; Wong, Sandy W; Maus, Marcela V; Komanduri, Krishna V; Berliner, Nancy; Henter, Jan-Inge; Perales, Miguel-Angel; Frey, Noelle V; Teachey, David T; Frank, Matthew J; Shah, Nirali N.
Affiliation
  • Hines MR; Department of Pediatric Medicine, Division of Critical Care, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Knight TE; Pediatric Hematology and Oncology, Seattle Children's Hospital and the University of Washington School of Medicine, Seattle, Washington.
  • McNerney KO; Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St. Petersburg, Florida.
  • Leick MB; Cellular Immunotherapy Program and Blood and Marrow Transplant Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts.
  • Jain T; Division of Hematological Malignancies and Bone Marrow Transplantation, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.
  • Ahmed S; Departments of Lymphoma and Myeloma and Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Frigault MJ; Cellular Immunotherapy Program and Blood and Marrow Transplant Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts.
  • Hill JA; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, Washington.
  • Jain MD; Moffitt Cancer Center, Tampa, Florida.
  • Johnson WT; Department of Medicine, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Lin Y; Division Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Rochester, Minnesota.
  • Mahadeo KM; Pediatric Transplantation and Cellular Therapy, Duke University, Durham, North Carolina.
  • Maron GM; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, and Department of Pediatrics, University of Tennessee Health Science Center College of Medicine, Memphis, Tennessee.
  • Marsh RA; University of Cincinnati, and Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Neelapu SS; Departments of Lymphoma and Myeloma and Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Nikiforow S; Division of Hematologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Ombrello AK; Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland.
  • Shah NN; Bone Marrow Transplant and Cellular Therapy Program, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Talleur AC; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee and Department of Pediatrics, University of Tennessee Health Science Center College of Medicine, Memphis, Tennessee.
  • Turicek D; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Vatsayan A; Division of Blood and Marrow Transplantation, Children's National Health System, Washington, District of Columbia.
  • Wong SW; UCSF Health Division of Hematology and Oncology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.
  • Maus MV; Cellular Immunotherapy Program and Blood and Marrow Transplant Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts.
  • Komanduri KV; UCSF Health Division of Hematology and Oncology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.
  • Berliner N; Brigham and Women's Hospital, Boston, Massachusetts.
  • Henter JI; Division of Pediatric Oncology and Surgery, Department of Women's and Children's Health, Karolinska Institute, and Department of Paediatric Oncology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Perales MA; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Frey NV; Division of Hematology-Oncology, Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Teachey DT; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Frank MJ; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.
  • Shah NN; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: Nirali.Shah@nih.gov.
Transplant Cell Ther ; 29(7): 438.e1-438.e16, 2023 07.
Article in En | MEDLINE | ID: mdl-36906275

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neurotoxicity Syndromes / Lymphohistiocytosis, Hemophagocytic Type of study: Etiology_studies / Risk_factors_studies Limits: Adult / Child / Humans Country/Region as subject: America do norte Language: En Journal: Transplant Cell Ther Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neurotoxicity Syndromes / Lymphohistiocytosis, Hemophagocytic Type of study: Etiology_studies / Risk_factors_studies Limits: Adult / Child / Humans Country/Region as subject: America do norte Language: En Journal: Transplant Cell Ther Year: 2023 Type: Article